See also this year's filing and all EDGAR filings for this company.
PDF Report 0001645469_2022_Monopar_Therapeutics.pdf
Logs
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001645469')"} |
Graph
Absolute values for 0001645469, Monopar Therapeutics
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 20,521,614 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 0 |
3 | remainder_Assets | 0 |
4 | LiabilitiesCurrent | 0 |
5 | LiabilitiesNoncurrent | 0 |
6 | remainder_Liabilities | 1,580,543 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 2,634,040 |
9 | ResearchAndDevelopmentExpense | 6,493,208 |
10 | remainder_Expenses | 0 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | 24,024 |
13 | remainder_ComprehensiveNetIncome | 4,713 |
yvar | yval | |
---|---|---|
0 | Assets | 20,521,614 |
1 | Liabilities | 1,580,543 |
2 | Expenses | 9,127,248 |
3 | Revenues | 0 |
4 | StockholdersEquity | 18,941,071 |
5 | NetIncome | -9,103,224 |
6 | ComprehensiveNetIncome | -9,100,868 |
7 | BaseVar | 15,629,071 |
8 | EconomicCapitalRatio | 2.12 |